Table of Contents Table of Contents
Previous Page  49 148 Next Page
Information
Show Menu
Previous Page 49 148 Next Page
Page Background

[5]

Hafron J, Mitra N, Dalbagni G, Bochner B, Herr H, Donat SM. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer? J Urol 2005;173:1513–7

.

[6]

Horovitz D, Turker P, Bostrom PJ, et al. Does patient age affect survival after radical cystectomy? BJU Int 2012;110:486–93

.

[7]

Figueroa AJ, Stein JP, Dickinson M, et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer 1998;83:141–7.

[8]

Rink M, Dahlem R, Kluth L, et al. Older patients suffer from adverse histopathological features after radical cystectomy. Int J Urol 2011;18:576–84

.

[9]

Liberman D, Lughezzani G, Sun M, et al. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology 2011;77:660–6.

[10]

Pollack A, Zagars GK, Dinney CP, Swanson DA, Von Eschenbach AC. Preoperative radiotherapy for muscle-invasive bladder carcinoma: Long term follow-up and prognostic factors for 338 patients. Cancer 1994;74:2819–27.

[11]

Guillotreau J, Miocinovic R, Gam X, et al. Outcomes of laparoscopic and robotic radical cystectomy in the elderly patients. Urology 2012;79:585–90

.

[12]

Fontana PP, Gregorio SA, Rivas JG, et al. Perioperative and survival outcomes of laparoscopic radical cystectomy for bladder cancer in patients over 70 years. Cent European J Urol 2015;68:24–9.

[13]

Bostrom PJ, Mirtti T, Kossi J, Laato M, Nurmi M. Twenty-year experience of radical cystectomy for bladder cancer in a medi- um-volume centre. Scand J Urol Nephrol 2009;43:357–64

.

[14]

Nishiyama H, Habuchi T, Watanabe J, et al. Clinical outcome of a large-scale multi-institutional retrospective study for locally ad- vanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Eur Urol 2004;45:176–81

.

[15]

Leveridge MJ, Siemens DR, Mackillop WJ, et al. Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study. Urology 2015;85:791–8.

[16]

Fairey AS, Kassouf W, Aprikian AG, et al. Age > 80 years is indepen- dently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database. Urol Oncol 2012;30:825–32.

[17]

Patel MI, Bang A, Gillatt D, Smith DP. Contemporary radical cystec- tomy outcomes in patients with invasive bladder cancer: a popu- lation-based study. BJU Int 2015;116:18–25

.

[18]

Hara T, Matsuyama H, Kamiryo Y, et al. Use of preoperative perfor- mance status and hemoglobin concentration to predict overall survival for patients aged 75 years after radical cystectomy for treatment of bladder cancer. Int J Clin Oncol 2016;21:139–47.

[19]

Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001;165:1111–6.

[20]

Zakaria A, Santos F, Kassoul W, Tanguay S, Aprikian A. Survival after radical cystectomy for bladder cancer in relation to prior non- muscle invasive disease in Quebec. Urol Int 2016;97:49–53.

[21]

Chromecki TF, Mauermann J, Cha EK, et al. Multicenter validation of the prognostic value of patient age in patients treated with curative cystectomy. World J Urol 2012;30:753–9.

[22]

Gore JL, Kwan L, Saigal CS, Litwin MS. Marriage and mortality in bladder carcinoma. Cancer 2005;104:1188–94.

[23]

Morgan TM, Barocas DA, Penson DF, et al. Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. J Urol 2012;80:632–40

.

[24]

Goossens-Laan CA, Leliveld AM, Verhoeven RH, et al. Effects of age and comorbidity on treatment and survival of patients with mus- cle-invasive bladder cancer. Int J Cancer 2014;135:905–12

.

[25]

Hayter CR, Paszat LF, Groome PA, Schulze K, Mackillop WJ. A population-based study of the use and outcome of radical radiotherapy for invaisve bladder cancer. Int J Radiat Oncol Biol Phys 1999;45:1239–45.

[26]

Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF. Clinical variables which serve as predictors of cancer-specific sur- vival among patients treated with radical cystectomy for transi- tional cell carcinoma of the bladder and prostate. Cancer 1994;73: 1708–15.

[27]

Yamanaka K, Miyake H, Hara I, Inoue TA, Fujisawa M. Significance of radical cystectomy for bladder cancer in patients over 80 years old. Int Urol Nephrol 2007;39:209–14

.

[28]

Nielsen ME, Shariat SF, Karakiewicz PI, et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 2007;51:699–708.

[29]

Madersbacher S, Bauer W, Willinger M, Wehrberger C, Berger I, Bro¨ssner C. Radical cystectomy for bladder cancer in the 70+ population: a nation-wide registry analysis of 845 patients. Urol Int 2010;85:287–90.

[30]

Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW. Radical cystectomy in octogenarians–does morbidity outweigh the potential survival benefits? J Urol 2010;183:2171–7.

[31]

Dotan K, Kavanagh O, Yossepowitch, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 2007;178:2308–13.

[32]

Mak RH, Hunt D, Shipley WU, et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-pre- serving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol 2014;32:3801–9

.

[33]

Fossa SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 1993;72: 3036–43.

[34]

Knap MM, Lundbeck F, Overgaard J. Early and late treatment- related morbidity following radical cystectomy. Scan J Urol Nephrol 2004;38:153–60

.

[35]

Clark PE, Stein JP, Groshen SG, et al. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 2005;104:36–43

.

[36]

Roghmann F, Sukumar S, Ravi P, et al. Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care. Urol Int 2014;92:27–34.

[37]

Tilki D, Reich O, Karakiewicz PI, et al. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associ- ated with significantly worse outcome. Eur Urol 2010;58:112–7

.

[38]

Schiffmann J, Larcher A, Sun M, et al. Contemporary 90-day mor- tality rates after radical cystectomy in the elderly. Eur J Surg Oncol 2014;40:1738–45.

[39]

Novotny V, Fro¨hner M, Zastrow S, Oehlschlaeger S, Weißflog C, Wirth MP. C94 Radical cystectomy in patients over 75 years of agewith one or more severe comorbidities. Eur Urol Suppl 2012;11:104

.

[40]

Fairey A, Chetner M, Metcalfe J, et al. Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta urology Institute Radical cystectomy database. J Urol 2008;180:128–34.

[41]

Morgan TM, Keegan KA, Barocas DA, et al. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol 2011;186:829–34.

[42]

Abdollah F, Sun M, Schmitges J, et al. Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study. Ann Surg Oncol 2012;19:309–17

.

[43]

Isbarn H, Karakiewicz PI, Shariat SF, et al. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. J Urol 2009;182:459–65

.

E U R O P E A N U R O L O G Y 7 3 ( 2 0 1 8 ) 4 0 – 5 0

49